FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a therapeutic anti-inflammatory composition, which contains one or several polyphenols and two or more carotenoids, which are selected from the group, consisting of lutein, lycopene and β-carotene, where the polyphenols are selected from the group consisting of carnosic acid, quercetin, resveratrol and gallic acid, in a specified quantity; to the method of inhibition or reduction of superoxide-ions formation, NO, TNF-α and/or PGE2 in a subject-mammal, which the said composition is introduced to; to the method of treating pathological conditions, in which superoxide-ions, NO, TNF-α and/or PGE2 function as a modulator or mediator of the said condition of the subject-mammal, which the said composition is introduced to; to the application of a combination of one or several polyphenols and two or more carotenoids, selected from the group, which consists of lutein, lycopene and β-carotene, where the polyphenols are selected from the group, consisting of carnosic acid, quercetin, resveratrol and gallic acid, in a specified quantity.
EFFECT: synergetic interaction of the polyphenol compounds with carotenoids in the inhibition of inflammation pathways is achieved.
28 cl, 11 dwg, 4 ex
